Dr. Mathew Davis received his Medical Degree at the Drexel University, formerly the Medical College of Pennsylvania, in 1994. Dr Davis earned his undergraduate degree from the University of Pennsylvania. Dr. Davis also received his pharmacy degree at Temple University in 1989. Dr Davis has held high level clinical and research positions in several pharmaceutical companies including Dr. Reddy's Laboratories, Eisai, URL Pharma Inc, and Lupin.
Three of Kidney C.O.P.'s five active ingredients are GRAS, the fourth is listed within National Institutes of Health, Office of Dietary Supplements Fact Sheet Magnesium along with recommended Daily Values and the fifth is ground Musa Paradisiaca (banana stems) a natural food consumed throughout the world. Government Documentation that is a GRAS Ingredient can be found in CFR Government Federal Code of Regulations Title 21 - Citric Acid 21 CFR 184.1033 - Inositol (IP6) (Phytin) Phytic Acid 21 CFR 184 1370 - Pyridoxine Hydrochloride 21 CFR 184.1676
Manufacturer is located in Davie, Florida and has been certified by National Sanitation Foundation (NSF) International to comply with GMP (Good Manufacturing Practices). NSF International was founded in 1944 from the University of Michigan's School of Public Health as the National Sanitation Foundation (NSF) to standardize sanitation and food safety requirements. The recent GMP certification number is C0024494-CS-1 and is dated January 27, 2020. A copy of GMP certification is available upon request.
Each manufactured batch of Kidney C.O.P. is tested at Arnet Pharmaceutical located in Davie, Florida for product potency. Every batch tested for "potency" must surpass 100 of claim for every active ingredient or it cannot be released for encapsulation and bottling by Arnet Pharmaceutical. Kidney C.O.P. formulation is also tested for the long term stability of product potency for three years. Stability of a product means how long it can maintain its original form without any major changes under the influence various environmental factors like temperature, humidity, and light. For validating the long term stability and to be able to provide proper product expiration dating, the first three lots of Kidney C.O.P. (lot numbers 703885, 703886, and 703887) where tested for stability. Stability studies have passed for long term stability (3 years). The studies began in 04 2017, and finished in 04 2020. Lots were tested for stability at 3 months, 6 months, 9 months, 12 months, 18 months, 24 months, and 36 months. The most recent, 36 months stability testing conducted by Arnet Pharmaceutical, Davie Florida , received results during 05 2020. Copies of stability studies are available upon request.
------------------------
These statements have not been evaluated by the Food Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Supporting studies and testing results documenting the 99 inhibition in the rate of calcium oxalate stone crystal growth can be found in the United States Patent 9,233,135, under Table 2 Labeled Data Analysis for Slope Test. Control Vehicle Test Solution 1.
US Patent Numbers: 9,233,135, 9,492,491 9,623,006 9,789,152 and 10,471,115. Most recent patent is dated February 20, 2020.
Many of Kidney C.O.P.'s active ingredients (or combination of) have been tested in clinical studies have shown to have an effect inhibiting calcium oxalate crystal growth. Many of these clinical studies are found in the five patents: 9,233,135 9,492,491 9,623,006 9,789,152 10,471,115 - pgs 1 - 3 of each patent. Just a few of these clinical studies are listed:
